Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay B Wish

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|September 19, 2007
Assessing iron status: beyond serum ferritin and transferrin saturationJay B Wish
Kidney Medicine|October 22, 2020
Erythropoiesis-Stimulating Agent Hyporesponsiveness and Adverse Outcomes: Guilty as Charged?Jay B Wish
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 25, 2002
Can evidence drive the development of a sound national EPO reimbursement policy?Jay B Wish
Nephrology News & Issues|August 19, 2006
Should patients get EPO subcutaneously?Jay B Wish
Kidney International Reports|July 26, 2021
Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors for the Treatment of Anemia in CKD: Additional Pieces of the Jigsaw PuzzleJay B Wish
Journal of the American Society of Nephrology : JASN|September 7, 2018
Perspective: Will We Ever Know the Optimal Hgb Level in ESRD?Jay B Wish
Kidney International Reports|September 19, 2019
Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice?Jay B Wish
Kidney International|January 14, 2011
Anemia management under a bundled payment policy for dialysis: a preview for the United States from JapanJay B Wish
Nephrology News & Issues|May 13, 2010
Fistula First: myth vs. factJay B Wish
Journal of the American Society of Nephrology : JASN|July 27, 2014
Catheter last, fistula not-so-firstJay B Wish
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Clinical Journal of the American Society of Nephrology : CJASN|September 19, 2007
Assessing iron status: beyond serum ferritin and transferrin saturationJay B Wish
Kidney Medicine|October 22, 2020
Erythropoiesis-Stimulating Agent Hyporesponsiveness and Adverse Outcomes: Guilty as Charged?Jay B Wish
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 25, 2002
Can evidence drive the development of a sound national EPO reimbursement policy?Jay B Wish
Nephrology News & Issues|August 19, 2006
Should patients get EPO subcutaneously?Jay B Wish
Kidney International Reports|July 26, 2021
Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors for the Treatment of Anemia in CKD: Additional Pieces of the Jigsaw PuzzleJay B Wish
Journal of the American Society of Nephrology : JASN|September 7, 2018
Perspective: Will We Ever Know the Optimal Hgb Level in ESRD?Jay B Wish
Kidney International Reports|September 19, 2019
Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice?Jay B Wish
Kidney International|January 14, 2011
Anemia management under a bundled payment policy for dialysis: a preview for the United States from JapanJay B Wish
Nephrology News & Issues|May 13, 2010
Fistula First: myth vs. factJay B Wish
Journal of the American Society of Nephrology : JASN|July 27, 2014
Catheter last, fistula not-so-firstJay B Wish
Pageof 9